Prescription Drugs Pricing Now Competitive After Patient Doctor Alliance

Prescription drugs pricing may become more competitive following an alliance between doctors, patients, pharmacies, and electronic health record companies. More than half of U.S. physicians and nearly two-thirds of patients will now be able to view information about benefits and drug costs to make decisions together during office visits.

 prescription drugs



Prescription Drugs: New Partnership

Surescripts, six electronic health record vendors, CVS Health, and Express Scripts announced a new joint effort this week to deliver data about prescription benefits and pricing to doctors and patients at the point of care.

Their  goal is to reduce prescription drug costs for patients.


Prescription Drugs: How This Alliance Works


Electronic health record companies; Allscripts, Cerner, GE, Epic, Practice Fusion and Aprima will integrate patient benefit and drug price information and recommend lower priced drugs where applicable. CVS and Express Scripts are the participating pharmacies.

Taken together, the EHR companies and pharmacy benefit managers comprise 53 percent of U.S. doctors and nearly 66 percent of patients.

This weeks announcement follows a yearlong pilot program that generated 3.75 million transactions. Benefits and pricing information was delivered to both prescribers and patients with price savings realized.


Prescription Drugs: Future Plans

The participants which also includes Surescripts Real-Time Prescription Benefit, Prior Authorization and e-Prescribing technologies, are working to be fully operational by early 2018.

The goal is to reduce prescription drug prices. Therefore, any doctor using EHRs from Epic, Allscripts, Cerner, GE Healthcare, Practice Fusio or Aprima, and whose patients drug benefits are managed by CVS or E Scripts, will be able to find the lowest prescription drug price.



The new alliance between EHR’s, doctors, patients, and pharmacies is a positive development and should turn out to be a win-win for patients and the health care industry.

Leave a Comment